Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.56 | 0.0003 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |